Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.

Caesar, Robert

Caesar, Robert.

Affiliation

Caesar R; The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden. Electronic address: Robert.Caesar@wlab.gu.se.

Can J Diabetes ; 43(3): 224-231, 2019 Apr.

Article in En | MEDLINE | ID: mdl-30929665

Subject(s)

Diabetes Mellitus, Type 2/microbiology; Dysbiosis/therapy; Gastrointestinal Microbiome; Glucose/metabolism; Diabetes Mellitus, Type 2/immunology; Diabetes Mellitus, Type 2/metabolism; Diet Therapy; Dietary Fiber/therapeutic use; Fecal Microbiota Transplantation; Gastrointestinal Microbiome/drug effects; Humans; Immunity, Innate; Metformin/adverse effects; Metformin/therapeutic use; Probiotics/therapeutic use

Key words

acides gras à chaîne courte; diabetes; diabète; glucose metabolism; gut microbiota; metagenome; metformin; metformine; microbiote intestinal; métabolisme des glucides; métagénome; short-chain fatty acids

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dysbiosis / Gastrointestinal Microbiome / Glucose Limits: Humans Language: En Journal: Can J Diabetes Year: 2019 Document type: Article Country of publication: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google